-transparent.png){kind=logo}
Thirty-seven children treated with netilmicin during the neonatal period were seen at follow-up at the age of 2-4 years to investigate for possible vestibular damage caused by netilmicin therapy. No definite vestibular damage could be found in these 37 patients, including three patients in whom greatly elevated serum concentrations of netilmicin had been measured. The present study confirms previous findings in adults showing a low ototoxicity of netilmicin.
Related Publications
A M Hauch, and
B Peitersen, and
E Peitersen
October 1990,
Acta paediatrica Scandinavica,
A M Hauch, and
B Peitersen, and
E Peitersen
July 1961,
The Journal of pediatrics,
A M Hauch, and
B Peitersen, and
E Peitersen
January 2010,
Vestnik otorinolaringologii,
A M Hauch, and
B Peitersen, and
E Peitersen
January 1983,
Pediatric pharmacology (New York, N.Y.),
A M Hauch, and
B Peitersen, and
E Peitersen
June 1992,
Anales espanoles de pediatria,
A M Hauch, and
B Peitersen, and
E Peitersen
January 1968,
Acta paediatrica Belgica,
A M Hauch, and
B Peitersen, and
E Peitersen
January 1983,
Akusherstvo i ginekologiia,
A M Hauch, and
B Peitersen, and
E Peitersen
May 1961,
Pediatric clinics of North America,
A M Hauch, and
B Peitersen, and
E Peitersen
February 2005,
Journal de gynecologie, obstetrique et biologie de la reproduction,
A M Hauch, and
B Peitersen, and
E Peitersen
November 1970,
Pediatric clinics of North America,
